These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 26363058)

  • 1. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1.
    Hsu P; Santner-Nanan B; Hu M; Skarratt K; Lee CH; Stormon M; Wong M; Fuller SJ; Nanan R
    J Immunol; 2015 Oct; 195(8):3665-74. PubMed ID: 26363058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
    Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
    PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
    Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
    Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
    Schmidt A; Éliás S; Joshi RN; Tegnér J
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 inhibits the development of regulatory T cells via STAT3.
    Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
    Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
    O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
    J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in many flavors control asthma.
    Ray A; Khare A; Krishnamoorthy N; Qi Z; Ray P
    Mucosal Immunol; 2010 May; 3(3):216-29. PubMed ID: 20164832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
    Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.
    Kshirsagar S; Riedl M; Billing H; Tönshoff B; Thangavadivel S; Steuber C; Staude H; Wechselberger G; Edelbauer M
    J Immunol; 2014 Nov; 193(10):4895-903. PubMed ID: 25339666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.